Danimer Scientific, Inc.

    Danimer Scientific, Inc.

    OOTC:DNMR
    - -
    USD
    - -
    - -
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    15.09
    22.4
    25.25
    21.06
    18.31
    13.54
    Basic EPS, GAAP
    -9.11
    -4.19
    -25.83
    -71.12
    -60.97
    -40.23
    Free Cash Flow per Basic Share
    -17.84
    -24.64
    -106.74
    -89.55
    -29.39
    -25.99
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -23.3
    -27.81
    -51.09
    -118.16
    -178.08
    -190.24
    Tangible Book Value per Share
    6.78
    167.62
    151.68
    117.38
    78.52
    49.14
    Basic Weighted Avg Shares
    2
    2
    2
    3
    3
    3
    Sales/Revenue/Turnover
    32
    47
    59
    53
    47
    37
    Operating Margin (%)
    -32.16
    -33.25
    -169.18
    -232.89
    -268.15
    -232.12
    Depreciation Expense
    4
    5
    11
    20
    29
    30
    Net Income, GAAP
    -20
    -9
    -60
    -180
    -155
    -111
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -60.33
    -18.7
    -102.31
    -337.78
    -333.03
    -297.1
    Working Capital
    -15
    352
    297
    100
    92
    49
    LT Debt
    91
    56
    284
    309
    403
    403
    Total Equity
    17
    356
    500
    378
    278
    212
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    5
    11
    10
    LT Borrowings
    384
    387
    382
    LT Finance Leases
    22
    21
    21
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    3
    3
    3
    Market Capitalization
    112
    64
    50

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    105
    87
    70
    Cash, Cash Equivalents & STI
    57
    40
    22
    Accounts Receivable, Net
    12
    11
    12
    Inventories
    26
    26
    26
    Total Current Liabilities
    16
    19
    21
    Payables & Accruals
    10
    6
    10
    ST Debt
    5
    11
    10
    Deferred Revenue
    1
    1
    1

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -26.37%
    Free Cash Flow
    - -
    - -
    -66.88%
    Net Income, GAAP
    - -
    - -
    -13.51%
    Sales/Revenue/Turnover
    - -
    - -
    -12.28%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    15
    13
    10
    15
    53
    2023
    12
    13
    11
    11
    47
    2024
    10
    8
    9
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -10.48
    -12.05
    -37.5
    -11.07
    -71.12
    2023
    -14.38
    -15.4
    -15.74
    -15.44
    -60.97
    2024
    -10.49
    -7.78
    -7.3
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • businesswire.com

      Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

    • businesswire.com

      NYSE to Commence Delisting Proceedings Against Danimer Scientific, Inc. (DNMR)

    • businesswire.com

      Danimer Scientific Takes Action to Strengthen Capital Structure

    • prnewswire.com

      TerraNova Capital Equities announces three transactions totaling $45 Million

    • seekingalpha.com

      Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript

    • zacks.com

      Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Tops Revenue Estimates

    • businesswire.com

      Danimer Scientific Announces Third Quarter 2024 Results

    • businesswire.com

      Danimer Scientific Announces Release Date for Third Quarter 2024 Results

    • businesswire.com

      Danimer Scientific Announces Intention to Complete a Reverse Stock Split

    • businesswire.com

      Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action Lawsuit

    • businesswire.com

      Ningbo Homelink Eco-iTech and Danimer Scientific Announce Commercial Launch of Home Compostable Extrusion Coating Biopolymer Based on PHA

    • businesswire.com

      DoD Makes Award to Danimer Scientific via the Distributed Bioindustrial Manufacturing Program

    • zacks.com

      What Makes Danimer Scientific (DNMR) a New Buy Stock

    • seekingalpha.com

      Danimer Scientific, Inc (DNMR) Q2 2024 Earnings Call Transcript

    • zacks.com

      Danimer Scientific, Inc. (DNMR) Reports Q2 Loss, Lags Revenue Estimates

    • businesswire.com

      Danimer Scientific Announces Release Date for Second Quarter 2024 Results

    • businesswire.com

      Danimer Scientific Completes Dividend Distribution of Warrants to Stockholders

    • businesswire.com

      Danimer Scientific Receives Continued Listing Standard Notice from NYSE

    • businesswire.com

      Danimer Scientific Announces Steve Croskrey Retirement and Related Changes to the Company's Board of Directors

    • seekingalpha.com

      Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript